CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 81 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $12,000 | -58.6% | 2,332 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $29,000 | +26.1% | 2,332 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $23,000 | 0.0% | 2,332 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $23,000 | +76.9% | 2,332 | +52.7% | 0.00% | 0.0% |
| Q1 2020 | $13,000 | -7.1% | 1,527 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $14,000 | +55.6% | 1,527 | 0.0% | 0.00% | – |
| Q3 2019 | $9,000 | -50.0% | 1,527 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $18,000 | 0.0% | 1,527 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $18,000 | -5.3% | 1,527 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $19,000 | -17.4% | 1,527 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $23,000 | -11.5% | 1,527 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $26,000 | -25.7% | 1,527 | 0.0% | 0.00% | -50.0% |
| Q1 2018 | $35,000 | -12.5% | 1,527 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $40,000 | +122.2% | 1,527 | +28.6% | 0.00% | +100.0% |
| Q3 2017 | $18,000 | +5.9% | 1,187 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $17,000 | -15.0% | 1,187 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $20,000 | – | 1,187 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,135,289 | $46,246,000 | 5.88% |
| GREAT POINT PARTNERS LLC | 2,006,211 | $29,592,000 | 5.76% |
| Lyon Street Capital, LLC | 463,064 | $6,830,000 | 2.63% |
| SENZAR ASSET MANAGEMENT, LLC | 335,445 | $4,948,000 | 1.21% |
| INGALLS & SNYDER LLC | 1,209,062 | $17,834,000 | 0.93% |
| Senvest Management, LLC | 314,629 | $4,641,000 | 0.31% |
| KNOTT DAVID M | 45,000 | $664,000 | 0.28% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 262,569 | $3,873,000 | 0.15% |
| PRINCETON CAPITAL MANAGEMENT INC | 14,607 | $215,000 | 0.11% |
| Manchester Capital Management LLC | 19,984 | $295,000 | 0.05% |